{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:54:32Z","timestamp":1764996872070},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jbspin.2009.11.008","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T04:08:26Z","timestamp":1261454906000},"page":"6-12","source":"Crossref","is-referenced-by-count":27,"title":["Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: From risk factor identification to risk factor intervention"],"prefix":"10.1016","volume":"77","author":[{"given":"Marc","family":"Bardou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan N.","family":"Barkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.11.008_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pds.623","article-title":"Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France","volume":"10","author":"Clinard","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.jbspin.2009.11.008_bib2","doi-asserted-by":"crossref","first-page":"C27","DOI":"10.1016\/S0399-8320(04)95276-1","article-title":"Epidemiology of gastroduodenal complications associated with nonsteroidal anti-inflammatory drug use","volume":"28","author":"Merle","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","article-title":"Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands","volume":"29","author":"van der Hooft","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jbspin.2009.11.008_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820\u00a0patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2009.11.008_bib5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres","volume":"320","author":"Pouyanne","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2009.11.008_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","article-title":"Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756\u00a0patients","volume":"31","author":"Franceschi","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jbspin.2009.11.008_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1572-0241.2005.41833.x","article-title":"A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug use","volume":"100","author":"Lanas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2036.2008.03706.x","article-title":"National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use","volume":"28","author":"Abraham","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2009.11.008_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00002512-200724080-00005","article-title":"Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs","volume":"24","author":"Vonkeman","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jbspin.2009.11.008_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.gastro.2006.12.007","article-title":"Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population","volume":"132","author":"Garcia Rodriguez","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jbspin.2009.11.008_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MCG.0b013e3180318ac5","article-title":"Risk factors of peptic ulcer in 4943\u00a0inpatients","volume":"42","author":"Talamini","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/00365520701478758","article-title":"Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study","volume":"42","author":"Udd","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/rheumatology\/kel223","article-title":"Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study","volume":"46","author":"Rahme","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2009.11.008_bib14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cgh.2005.10.006","article-title":"Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review","volume":"4","author":"Papatheodoridis","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib18","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","article-title":"The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption","volume":"94","author":"Kaufman","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study","volume":"333","author":"Hallas","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2009.11.008_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/gast.1997.v112.pm9041228","article-title":"Evidence of aspirin use in both upper and lower gastrointestinal perforation","volume":"112","author":"Lanas","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2009.11.008_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2007.12.018","article-title":"Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin","volume":"6","author":"van Oijen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pds.1546","article-title":"Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity","volume":"17","author":"Lewis","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jbspin.2009.11.008_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00044011-200828110-00002","article-title":"Concomitant use of gastroprotective drugs among elderly NSAID\/COX-2 selective inhibitor users: a nationwide register-based study","volume":"28","author":"Johnell","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jbspin.2009.11.008_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3748\/wjg.v11.i9.1365","article-title":"Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: endoscopic findings, clinical management and outcome","volume":"11","author":"Thomopoulos","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/gut.32.7.730","article-title":"Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study","volume":"32","author":"Holvoet","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00228-005-0078-7","article-title":"Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy","volume":"62","author":"Silvani","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib29","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0016-5085(99)70545-7","article-title":"Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans","volume":"117","author":"Cryer","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2009.11.008_bib31","first-page":"A22","article-title":"Gastroprotection chez les patients sous AINS \u00e0 risque de complications digestives\u00a0: r\u00e9sultats d\u2019une enqu\u00eate observationnelle en m\u00e9decine g\u00e9n\u00e9rale","volume":"32","author":"Thiefin","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib32","first-page":"A27","article-title":"Trends and determination of adequate gastroprotection in chronic NSAID prescription","volume":"56","author":"van der Linden","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib33","first-page":"A28","article-title":"A new safety warning: decreased gastroprotection is associated with an increase of serious ulcer complication in elderly users of NSAIDS","volume":"56","author":"Singh","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","article-title":"Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications","volume":"4","author":"Goldstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2007.03358.x","article-title":"Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage","volume":"26","author":"van Soest","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2009.11.008_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jbspin.2009.11.008_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.02943.x","article-title":"Review article: the clinical pharmacology of proton pump inhibitors","volume":"23","author":"Sachs","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2009.11.008_bib41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.2003.010223","article-title":"Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries","volume":"63","author":"Woolf","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.11.008_bib43","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archinte.156.14.1530","article-title":"Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study","volume":"156","author":"Singh","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02649.x","article-title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","volume":"22","author":"Yeomans","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2009.11.008_bib45","first-page":"A27","article-title":"Early reintroduction of aspirin with proton pump inhibitors after endoscopic hemostasis for peptic ulcer bleeding: final results of a double blinded randomized study","volume":"56","author":"Sung","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2009.11.008_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cgh.2006.04.019","article-title":"Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications","volume":"4","author":"Lai","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib48","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib52","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1111\/j.1572-0241.2005.00302.x","article-title":"Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study","volume":"100","author":"Schaeverbeke","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib54","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2009.11.008_bib55","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(07)60234-7","article-title":"Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"369","author":"Laine","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib57","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.11.008_bib58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.gastro.2008.01.010","article-title":"The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs","volume":"134","author":"Targownik","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2009.11.008_bib59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","article-title":"Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor","volume":"95","author":"Goldstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2009.11.008_bib60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2009.11.008_bib61","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1053\/j.gastro.2008.07.067","article-title":"Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac","volume":"135","author":"Laine","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2009.11.008_bib62","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2009.11.008_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data","volume":"54","author":"Lewis","year":"2002","journal-title":"Br J Clin Pharmacol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T06:26:24Z","timestamp":1544768784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09001985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1297319X09001985"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.11.008","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}